Korea seeks to secure additional COVID-19 pills from Pfizer
Paxlovid, Pfizer's COVID-19 treatment pill, is seen being packaged in Ascoli, Italy, in this undated handout photo, Nov. 16. Reuters-YonhapKorea reports 109 COVID-19 deaths, first triple-digit tollBy Lee Hyo-jin The Korean government seeks to secure an additional supply of Pfizer's oral COVID-19 treatment, after the pill became the first oral antiviral drug to have been cleared by the U.S. drug regulator during the pandemic.“We are closely discussing with Pfizer supply deals additional to the pills for 70,000 people that we have already purchased,” Kim Ok-soo, a senior official at the Korea Disease Control and Prevention Agency (KDCA), said during a briefing, Thursday. “Details on shipment schedules, the supply amount and whom they will be used on will be announced later, in accordance with the emergency authorization approval from the Ministry of Food and Drug Safety.”If introduced, the pills will be used in treating COVID-19 patients undergoing home treatment, patients of high-risk groups as well as those showing mild and moderate symptoms, Kim said. The ann
